The American Journal of Medicine
Volume 111, Issue 8 , Pages 602-606 , 1 December 2001

Polycystic ovaries in hirsute women with normal menses

  • Enrico Carmina, MD

      Affiliations

    • Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York, USA
    • ,
  • Rogerio A Lobo, MD

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Rogerio A. Lobo, MD, Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, 622 West 168th Street, New York, New York 10032, USA
    • Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, New York, USA

Received 19 April 2001 ,Revised 2 August 2001 ,Accepted 24 August 2001.

References 

  1. Azziz R, Carmina E, Sawaya ME. Idiopathic hirsutism. Endocr Rev. 2000;21:347–362
  2. Carmina E, Lobo RA. Do hyperandrogenic women with normal menses have PCOS?. Fertil Steril. 1999;71:319–322
  3. Barnes RB, Rosenfield RL, Burnstein S, Ehrmann DA. Pituitary-ovarian responses to nafarelin testing in polycystic ovarian syndrome. N Engl J Med. 1989;30:559–565
  4. Dahlgren E, Janson PO, Johansson S, et al.  Women with polycystic ovary syndrome wedge resected in 1959 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fertil Steril. 1992;57:505–513
  5. Dahlgren E, Janson PO, Johansson S, et al.  Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women. Acta Obstet Gynecol Scand. 1992;71:559–604
  6. Mather KJ, Kwan F, Corenblum B. Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity. Fertil Steril. 2000;73:150–156
  7. Talbott E, Guzick K, Clerici A, et al.  Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol. 1995;15:821–826
  8. Carmina E, Lobo RA. Polycystic ovary syndrome (PCOS) (arguably the most common endocrinopathy is associated with significant morbidity in women). J Clin Endocrinol Metab. 1999;84:1987–1999
  9. Lobo RA, Carmina E. The importance of diagnosing the polycystic ovary syndrome. Ann Intern Med. 2000;132:989–993
  10. Hatch R, Rosenfield RL, Kim MH, et al.  Hirsutism (implications, etiology and management). Am J Obstet Gynecol. 1981;140:815–830
  11. Polson D, Wadsworth J, Adams J, et al.  Polycystic ovaries (a common finding in normal women). Lancet. 1988;1:870–872
  12. Lobo RA, Goebelsmann U. Evidence for reduced 3β-ol-hydroxysteroid dehydrogenase activity in some hirsute women thought to have polycystic ovary syndrome. J Clin Endocrinol Metab. 1981;53:394–400
  13. Hoffman DL, Klove K, Lobo RA. The prevalence and significance of elevated dehydroepiandrosterone sulfate in anovulatory women. Fertil Steril. 1984;42:76–81
  14. Stanczyk FZ, Chang L, Carmina E, et al.  Is 11β-hydroxyandrostenedione a better marker of adrenal androgen excess than dehydroepiandrosterone sulfate?. Am J Obstet Gynecol. 1991;166:1837–1842
  15. Lopes-Virella MF, Stone P, Ellis S, et al.  Cholesterol determination in high-density lipoproteins separated by three different methods. Clin Chem. 1977;23:882–884
  16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502
  17. Carmina E. Prevalence of idiopathic hirsutism. Eur J Endocrinol. 1998;139:421–423
  18. Azziz R, Waggoner WT, Ochoa T, et al.  Idiopathic hirsutism (an uncommon cause of hirsutism in Alabama). Fertil Steril. 1998;70:274–278
  19. Conway GS, Agrawal R, Betteridge DJ, et al.  Risk factors for coronary artery disease in lean and obese women with the polycystic ovary syndrome. Clin Endocrinol (Oxf). 1992;37:119–125
  20. Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1998;83:2964–2968
  21. Morales AJ, Laughlin GA, Butzow T, et al.  Insulin, somatotrophic, and luteinizing hormone axes in lean, and obese women with polycystic ovary syndrome (common and distinct features). J Clin Endocrinol Metab. 1996;81:2854–2864
  22. Wild RA, Alaupovic AP, Parker IJ. Lipid and apolipoprotein abnormalities in hirsute women. I. The association with insulin resistance. Am J Obstet Gynecol. 1992;166:1191–1196
  23. Guzick DS, Talbott EO, Sutton-Tyrrell K, et al.  Carotid atherosclerosis in women with polycystic ovary syndrome (initial results from a case-control study). Am J Obstet Gynecol. 1996;174:1224–1229
  24. Birdsall MA, Farquhar CM, White HD. Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization. Ann Intern Med. 1997;126:32–35
  25. Legro RS, Kunselman AR, Dodson WC, et al.  Prevalence and predictors of the risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome (a prospective, controlled study in 254 affected women). J Clin Endocrinol Metab. 1999;84:165–169

PII: S0002-9343(01)00979-2

The American Journal of Medicine
Volume 111, Issue 8 , Pages 602-606 , 1 December 2001

Article Tools